Lista de obras - Xavier Jais - Dominio Público Uruguay

A Clinical and Echocardiographic Score to Identify Pulmonary Hypertension Due to HFpEF.

artículo científico publicado en 2016

A rare case of sarcoidosis-associated pulmonary hypertension in a patient exposed to silica.

artículo científico publicado en 2016

Acute decompensated pulmonary hypertension.

artículo científico publicado en 2017

Advances in therapeutic interventions for patients with pulmonary arterial hypertension

artículo científico publicado en 2014

An extreme consequence of splenectomy in dehydrated hereditary stomatocytosis: gradual thrombo-embolic pulmonary hypertension and lung-heart transplantation.

artículo científico

Are indexed values better for defining exercise pulmonary hypertension?

artículo científico publicado en 2017

Association Between BMI and Obesity With Survival in Pulmonary Arterial Hypertension

scientific article published on 22 May 2018

Atypical vasculitis mimicking chronic thromboembolic pulmonary hypertension

artículo científico publicado en 2015

BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension.

artículo científico publicado en 2016

Balloon pulmonary angioplasty in a patient with chronic thromboembolic pulmonary hypertension

scientific article published on 01 September 2014

Birth control and pregnancy management in pulmonary hypertension

artículo científico publicado en 2013

Bosentan therapy for pulmonary arterial hypertension

scientific article published on 01 May 2005

Characteristics and prospective 2-year follow-up of children with pulmonary arterial hypertension in France.

artículo científico publicado en 2010

Characteristics of pulmonary arterial hypertension in affected carriers of a mutation located in the cytoplasmic tail of bone morphogenetic protein receptor type 2.

artículo científico publicado en 2015

Characterization of Pulmonary Arterial Hypertension Patients Walking More Than 450 m in 6 Min at Diagnosis

artículo científico publicado en 2010

Chemotherapy-induced pulmonary hypertension: role of alkylating agents.

artículo científico publicado en 2014

Chronic thromboembolic pulmonary hypertension

scientific article published on 12 November 2015

Chronic thromboembolic pulmonary hypertension complicating long-term cyproterone acetate therapy.

artículo científico publicado en 2014

Clinical and Hemodynamic Correlates of Pulmonary Arterial Stiffness in Incident, Untreated Patients With Idiopathic Pulmonary Arterial Hypertension

artículo científico publicado en 2018

Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.

artículo científico publicado en 2008

Clinical pharmacology of endothelin receptor antagonists used in the treatment of pulmonary arterial hypertension.

artículo científico publicado en 2015

Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.

artículo científico publicado en 2017

Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis.

artículo científico publicado en 2018

Comparative Safety and Tolerability of Prostacyclins in Pulmonary Hypertension

artículo científico publicado en 2016

Complications of Right Heart Catheterization Procedures in Patients With Pulmonary Hypertension in Experienced Centers

article

Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension.

artículo científico publicado en 2012

Corrigendum to "FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion" [Int. J. Cardiol. 202 (2016) 52-58].

artículo científico publicado en 2016

Criteria for diagnosis of exercise pulmonary hypertension.

artículo científico publicado en 2015

Current epoprostenol use in patients with severe idiopathic, heritable or anorexigen-associated pulmonary arterial hypertension: data from the French pulmonary hypertension registry

artículo científico publicado en 2014

Current management approaches to portopulmonary hypertension.

scientific article published on January 2011

Dead-space ventilation is linked to exercise capacity and survival in distal chronic thromboembolic pulmonary hypertension.

artículo científico publicado en 2017

Deleterious Effects of β-Blockers on Exercise Capacity and Hemodynamics in Patients With Portopulmonary Hypertension

artículo científico publicado en 2006

Deterioration of pulmonary hypertension and pleural effusion with bosutinib following dasatinib lung toxicity

artículo científico publicado en 2016

Diagnostic concordance of different criteria for exercise pulmonary hypertension in subjects with normal resting pulmonary artery pressure

artículo científico publicado en 2016

Diagnostic et prise en charge de l’hypertension pulmonaire postembolique : le rôle du pneumologue

artículo científico publicado en 2008

Direct-Acting Antiviral Medications for Hepatitis C Virus Infection and Pulmonary Arterial Hypertension.

artículo científico publicado en 2016

EBUS-TBNA in the differential diagnosis of pulmonary artery sarcoma and thromboembolism: Figure 1–

artículo científico publicado en 2012

Extracorporeal Life Support After Pulmonary Endarterectomy as a Bridge to Recovery or Transplantation: Lessons From 31 Consecutive Patients.

artículo científico publicado en 2016

FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion

artículo científico publicado en 2015

Factors predicting outcome after pulmonary endarterectomy.

artículo científico publicado en 2018

First identification of HIV-1 groups M and O dual infections in Europe

artículo científico publicado en 2004

Genetic counselling in a national referral centre for pulmonary hypertension.

artículo científico publicado en 2015

Goal-oriented therapy in pulmonary veno-occlusive disease: a word of caution.

artículo científico publicado en 2009

Guidelines for the diagnosis and treatment of pulmonary hypertension

artículo científico publicado en 2010

HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era.

scientific article published on January 2010

Haemodynamics and serial risk assessment in systemic-sclerosis associated pulmonary arterial hypertension

artículo científico publicado en 2018

Health-related quality of life of patients with pulmonary arterial hypertension associated with CHD: the multicentre cross-sectional ACHILLE study.

artículo científico publicado en 2016

Idiopathic pulmonary hypertension: what did we learn from genes?

artículo científico publicado en 2005

Immunosuppressive Therapy in Connective Tissue Diseases-Associated Pulmonary Arterial Hypertension

artículo científico publicado en 2006

Immunosuppressive therapy in lupus- and mixed connective tissue disease–associated pulmonary arterial hypertension: A retrospective analysis of twenty-three cases

article

Impact of High-Priority Allocation on Lung and Heart-Lung Transplantation for Pulmonary Hypertension.

artículo científico publicado en 2017

Impact of the initiation of balloon pulmonary angioplasty program on referral of patients with chronic thromboembolic pulmonary hypertension to surgery

artículo científico publicado en 2018

Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre ⬇️

artículo científico publicado el 1 de diciembre de 2009

Initial dual oral combination therapy in pulmonary arterial hypertension.

artículo científico publicado en 2016

Inspiratory muscle function, dynamic hyperinflation and exertional dyspnoea in pulmonary arterial hypertension.

artículo científico publicado en 2015

Intravenous Epoprostenol in Inoperable Chronic Thromboembolic Pulmonary Hypertension

artículo científico publicado en 2007

Left Ventricular Ejection Time in Acute Heart Failure Complicating Precapillary Pulmonary Hypertension

artículo científico publicado en 2013

Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry.

artículo científico publicado en 2016

Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension.

artículo científico publicado en 2008

Long-term outcome in liver transplantation candidates with portopulmonary hypertension.

artículo científico publicado en 2016

Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil

artículo científico publicado en 2009

Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension.

artículo científico publicado en 2006

Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study.

artículo científico publicado en 2017

Long-term outcomes of pulmonary arterial hypertension under specific drug therapy in Eisenmenger syndrome.

artículo científico publicado en 2016

Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.

artículo científico publicado en 2005

Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension

artículo científico publicado en 2010

Loss of Vascular Distensibility During Exercise Is an Early Hemodynamic Marker of Pulmonary Vascular Disease

artículo científico publicado en 2015

Lung and heart-lung transplantation for systemic sclerosis patients. A monocentric experience of 13 patients, review of the literature and position paper of a multidisciplinary Working Group

artículo científico publicado en 2014

Lung capillary blood volume and membrane diffusion in precapillary pulmonary hypertension

artículo científico publicado en 2016

L’hypertension artérielle pulmonaire associée au VIH

scientific article published on 22 March 2012

Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension.

artículo científico publicado en 2017

Mechanisms of exertional dyspnoea in pulmonary veno-occlusive disease with EIF2AK4 mutations

artículo científico publicado en 2014

Mediastinal Fibrosis Mimicking Proximal Chronic Thromboembolic Disease

artículo científico publicado en 2012

Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature.

artículo científico publicado en 2014

Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models

artículo científico publicado en 2015

New pharmacotherapy options for pulmonary arterial hypertension.

artículo científico

Occult alveolar haemorrhage in pulmonary veno-occlusive disease.

artículo científico publicado en 2006

Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease

artículo científico publicado en 2015

Outcome of adults with Eisenmenger syndrome treated with drugs specific to pulmonary arterial hypertension: A French multicentre study

artículo científico publicado en 2017

Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 study.

artículo científico publicado en 2009

Poor Subpleural Perfusion Predicts Failure After Balloon Pulmonary Angioplasty for Nonoperable Chronic Thromboembolic Pulmonary Hypertension

artículo científico publicado en 2018

Portopulmonary Hypertension

artículo científico publicado en 2008

Potts shunt in children with idiopathic pulmonary arterial hypertension: long-term results.

artículo científico publicado en 2012

Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension.

artículo científico publicado en 2009

Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus: Results From the French Pulmonary Hypertension Registry

artículo científico publicado en 2017

Pulmonary Hypertension Complicating Fibrosing Mediastinitis

artículo científico publicado en 2015

Pulmonary Langerhans Cell Histiocytosis-Associated Pulmonary Hypertension

artículo científico publicado en 2012

Pulmonary arterial hypertension

artículo científico publicado en 2008

Pulmonary arterial hypertension

artículo científico publicado en 2013

Pulmonary arterial hypertension in patients treated with interferon.

artículo científico publicado en 2014

Pulmonary arterial hypertension masquerading as severe refractory asthma

artículo científico publicado en 2008

Pulmonary arterial hypertension: a rare complication of primary Sjögren syndrome: report of 9 new cases and review of the literature

artículo científico publicado en 2007

Pulmonary artery hypertension associated with connective tissue diseases

artículo científico publicado en 2003

Pulmonary hypertension associated with neurofibromatosis type 1

artículo científico publicado en 2018

Pulmonary hypertension in lymphangioleiomyomatosis: characteristics in 20 patients

artículo científico publicado en 2012

Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease.

artículo científico publicado en 2017

Pulmonary veno-occlusive disease

artículo científico publicado en 2009

Pulmonary veno-occlusive disease

artículo científico publicado en 2016

Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis

artículo científico publicado en 2009

Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology.

artículo científico publicado en 2008

Pulmonary veno-occlusive disease: recent progress and current challenges.

artículo científico publicado en 2010

RV Fractional Area Change and TAPSE as Predictors of Severe Right Ventricular Dysfunction in Pulmonary Hypertension: A CMR Study

artículo científico publicado en 2018

Rapid Switch From Intravenous Epoprostenol to Intravenous Treprostinil in Patients With Pulmonary Arterial Hypertension

artículo científico publicado en 2007

Reduced deformability of circulating erythrocytes: A marker of hyposplenism

scientific article published on 27 July 2012

Relation between left ventricular ejection time and pulmonary hemodynamics in pulmonary hypertension

artículo científico publicado en 2015

Response to Letter Regarding Article, “Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension”

scientific article published on 01 September 2015

Response to Letter Regarding Article, “Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Model”

artículo científico publicado en 2016

Resting pulmonary artery pressure of 21–24 mmHg predicts abnormal exercise haemodynamics

artículo científico publicado en 2016

Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension

artículo científico publicado en 2017

Severe pulmonary hypertension during pregnancy: mode of delivery and anesthetic management of 15 consecutive cases.

artículo científico publicado en 2005

Splenectomy and chronic thromboembolic pulmonary hypertension.

artículo científico publicado en 2005

Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension.

artículo científico publicado en 2010

Targeted therapies in pulmonary arterial hypertension

artículo científico

The Prognostic Value of Follow-up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.

artículo científico publicado en 2017

The association between resting and mild-to-moderate exercise pulmonary artery pressure

artículo científico publicado en 2011

The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension: a 1-year follow-up study

artículo científico publicado en 2006

The potential for macitentan, a new dual endothelin receptor antagonist, in the treatment of pulmonary arterial hypertension.

artículo científico publicado en 2014

Therapeutic advances in pulmonary arterial hypertension.

scientific article published on August 2008

Traitement chirurgical de l’hypertension pulmonaire post-embolique

artículo científico publicado en 2014

Traitement de l’hypertension artérielle pulmonaire

artículo científico publicado en 2005

Tunnelled central venous line-associated infections in patients with pulmonary arterial hypertension treated with intravenous prostacyclin

artículo científico publicado en 2015

Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study

artículo científico publicado en 2014

Usefulness of Cardiovascular Magnetic Resonance Indices to Rule In or Rule Out Precapillary Pulmonary Hypertension

artículo científico publicado en 2015

Usefulness of first-line combination therapy with epoprostenol and bosentan in pulmonary arterial hypertension: An observational study

artículo científico publicado en 2011

[Chronic post-embolic pulmonary artery hypertension]

artículo científico publicado en 2007

[Diagnosis and classification of pulmonary arterial hypertension]

artículo científico publicado en 2005

[Pulmonary arterial hypertension associated with common diseases: connective-tissue diseases, HIV infection and portal hypertension]

artículo científico publicado en 2008

[Pulmonary arterial hypertension due to tumor emboli]

artículo científico publicado en 2007

[Pulmonary arterial hypertension].

artículo científico publicado en 2005

[Pulmonary veno-occlusive disease].

artículo científico publicado en 2018

[Treatment of pulmonary arterial hypertension in 2011: what's new since the 2009 ERS/ESC guidelines?].

artículo científico publicado en 2011

[Treatment of pulmonary arterial hypertension]

scientific article published on 01 June 2010

[Treatment of pulmonary arterial hypertension].

artículo científico publicado en 2014

Lista de obras de Xavier Jais

A Clinical and Echocardiographic Score to Identify Pulmonary Hypertension Due to HFpEF.

A rare case of sarcoidosis-associated pulmonary hypertension in a patient exposed to silica.

Acute decompensated pulmonary hypertension.

Advances in therapeutic interventions for patients with pulmonary arterial hypertension

An extreme consequence of splenectomy in dehydrated hereditary stomatocytosis: gradual thrombo-embolic pulmonary hypertension and lung-heart transplantation.

Are indexed values better for defining exercise pulmonary hypertension?

Association Between BMI and Obesity With Survival in Pulmonary Arterial Hypertension

Atypical vasculitis mimicking chronic thromboembolic pulmonary hypertension

BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension.

Balloon pulmonary angioplasty in a patient with chronic thromboembolic pulmonary hypertension

Birth control and pregnancy management in pulmonary hypertension

Bosentan therapy for pulmonary arterial hypertension

Characteristics and prospective 2-year follow-up of children with pulmonary arterial hypertension in France.

Characteristics of pulmonary arterial hypertension in affected carriers of a mutation located in the cytoplasmic tail of bone morphogenetic protein receptor type 2.

Characterization of Pulmonary Arterial Hypertension Patients Walking More Than 450 m in 6 Min at Diagnosis

Chemotherapy-induced pulmonary hypertension: role of alkylating agents.

Chronic thromboembolic pulmonary hypertension

Chronic thromboembolic pulmonary hypertension complicating long-term cyproterone acetate therapy.

Clinical and Hemodynamic Correlates of Pulmonary Arterial Stiffness in Incident, Untreated Patients With Idiopathic Pulmonary Arterial Hypertension

Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.

Clinical pharmacology of endothelin receptor antagonists used in the treatment of pulmonary arterial hypertension.

Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.

Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis.

Comparative Safety and Tolerability of Prostacyclins in Pulmonary Hypertension

Complications of Right Heart Catheterization Procedures in Patients With Pulmonary Hypertension in Experienced Centers

Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension.

Corrigendum to "FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion" [Int. J. Cardiol. 202 (2016) 52-58].

Criteria for diagnosis of exercise pulmonary hypertension.

Current epoprostenol use in patients with severe idiopathic, heritable or anorexigen-associated pulmonary arterial hypertension: data from the French pulmonary hypertension registry

Current management approaches to portopulmonary hypertension.

Dead-space ventilation is linked to exercise capacity and survival in distal chronic thromboembolic pulmonary hypertension.

Deleterious Effects of β-Blockers on Exercise Capacity and Hemodynamics in Patients With Portopulmonary Hypertension

Deterioration of pulmonary hypertension and pleural effusion with bosutinib following dasatinib lung toxicity

Diagnostic concordance of different criteria for exercise pulmonary hypertension in subjects with normal resting pulmonary artery pressure

Diagnostic et prise en charge de l’hypertension pulmonaire postembolique : le rôle du pneumologue

Direct-Acting Antiviral Medications for Hepatitis C Virus Infection and Pulmonary Arterial Hypertension.

EBUS-TBNA in the differential diagnosis of pulmonary artery sarcoma and thromboembolism: Figure 1–

Extracorporeal Life Support After Pulmonary Endarterectomy as a Bridge to Recovery or Transplantation: Lessons From 31 Consecutive Patients.

FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion

Factors predicting outcome after pulmonary endarterectomy.

First identification of HIV-1 groups M and O dual infections in Europe

Genetic counselling in a national referral centre for pulmonary hypertension.

Goal-oriented therapy in pulmonary veno-occlusive disease: a word of caution.

Guidelines for the diagnosis and treatment of pulmonary hypertension

HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era.

Haemodynamics and serial risk assessment in systemic-sclerosis associated pulmonary arterial hypertension

Health-related quality of life of patients with pulmonary arterial hypertension associated with CHD: the multicentre cross-sectional ACHILLE study.

Idiopathic pulmonary hypertension: what did we learn from genes?

Immunosuppressive Therapy in Connective Tissue Diseases-Associated Pulmonary Arterial Hypertension

Immunosuppressive therapy in lupus- and mixed connective tissue disease–associated pulmonary arterial hypertension: A retrospective analysis of twenty-three cases

Impact of High-Priority Allocation on Lung and Heart-Lung Transplantation for Pulmonary Hypertension.

Impact of the initiation of balloon pulmonary angioplasty program on referral of patients with chronic thromboembolic pulmonary hypertension to surgery

Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre ⬇️

Initial dual oral combination therapy in pulmonary arterial hypertension.

Inspiratory muscle function, dynamic hyperinflation and exertional dyspnoea in pulmonary arterial hypertension.

Intravenous Epoprostenol in Inoperable Chronic Thromboembolic Pulmonary Hypertension

Left Ventricular Ejection Time in Acute Heart Failure Complicating Precapillary Pulmonary Hypertension

Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry.

Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension.

Long-term outcome in liver transplantation candidates with portopulmonary hypertension.

Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil

Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension.

Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study.

Long-term outcomes of pulmonary arterial hypertension under specific drug therapy in Eisenmenger syndrome.

Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.

Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension

Loss of Vascular Distensibility During Exercise Is an Early Hemodynamic Marker of Pulmonary Vascular Disease

Lung and heart-lung transplantation for systemic sclerosis patients. A monocentric experience of 13 patients, review of the literature and position paper of a multidisciplinary Working Group

Lung capillary blood volume and membrane diffusion in precapillary pulmonary hypertension

L’hypertension artérielle pulmonaire associée au VIH

Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension.

Mechanisms of exertional dyspnoea in pulmonary veno-occlusive disease with EIF2AK4 mutations

Mediastinal Fibrosis Mimicking Proximal Chronic Thromboembolic Disease

Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature.

Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models

New pharmacotherapy options for pulmonary arterial hypertension.

Occult alveolar haemorrhage in pulmonary veno-occlusive disease.

Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease

Outcome of adults with Eisenmenger syndrome treated with drugs specific to pulmonary arterial hypertension: A French multicentre study